Glenmark launches triple-drug combo for type 2 diabetes

Glenmark launches triple-drug combo for type 2 diabetes The Mumbai-based drug firm has introduced the combination of Teneligliptin, Dapagliflozin and Metformin under the brand name Zita.

from Moneycontrol Business News https://ift.tt/npOFKuc

No comments:

Post a Comment

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...